Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cost of Goods Sold
\$2,675 Mil (TTM As of Sep. 2016)

Valeant Pharmaceuticals International Inc's cost of goods sold for the three months ended in Sep. 2016 was \$658 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Sep. 2016 was \$2,675 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Valeant Pharmaceuticals International Inc's Gross Margin for the three months ended in Sep. 2016 was 73.46%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Valeant Pharmaceuticals International Inc's Inventory Turnover for the three months ended in Sep. 2016 was 0.50.

Definition

Cost of goods sold (COGS) refers to the Inventory costs of those goods a business has sold during a particular period.

Valeant Pharmaceuticals International Inc Cost of Goods Sold for the trailing twelve months (TTM) ended in Sep. 2016 was 729.2 (Dec. 2015 ) + 629.9 (Mar. 2016 ) + 657.8 (Jun. 2016 ) + 658 (Sep. 2016 ) = \$2,675 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Valeant Pharmaceuticals International Inc's Gross Margin for the three months ended in Sep. 2016 is calculated as:

 Gross Margin = (Revenue - Cost of Goods Sold) / Revenue = (2479.6 - 658) / 2479.6 = 73.46 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Valeant Pharmaceuticals International Inc's Inventory Turnover for the three months ended in Sep. 2016 is calculated as:

 Inventory Turnover = Cost of Goods Sold / Average Inventory = 658 / 1318.4 = 0.50

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 COGS 211 224 197 218 406 696 970 1,905 2,236 2,585

Valeant Pharmaceuticals International Inc Quarterly Data

 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 COGS 586 561 571 522 685 648 729 630 658 658
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)